In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9-Reference-Cited by-同舟云学术

In Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9

Published:2018-02 Issue:2 Volume:29 Page:223-233
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

He Zhi-Yao¹,Zhang Ya-Guang¹,Yang Yu-Han¹,Ma Cui-Cui¹,Wang Ping¹,Du Wei¹,Li Ling¹,Xiang Rong²,Song Xiang-Rong¹,Zhao Xia¹³,Yao Shao-Hua¹,Wei Yu-Quan¹

Affiliation:

1. Department of Pharmacy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, China

2. Department of Immunology, Medical School of Nankai University, Tianjin, China

3. Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, China.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2017.209

Reference58 articles.

1. Rationally engineered Cas9 nucleases with improved specificity

2. In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration

3. Applications of CRISPR technologies in research and beyond

4. CRISPR–Cas systems exploit viral DNA injection to establish and maintain adaptive immunity

5. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies;Critical Reviews in Oncology/Hematology;2024-09

2. Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer;International Journal of Molecular Sciences;2024-07-30

3. Revitalizing oral cancer research: Crispr-Cas9 technology the promise of genetic editing;Frontiers in Oncology;2024-06-10

4. The ethically significant difference between dual use and slippery slope arguments, in relation to CRISPR-Cas9: philosophical considerations and ethical challenges;Research Ethics;2024-03-17

5. Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine;Genes & Diseases;2024-01